Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 20890226)

1.

SOX10 expression in superficial spreading and nodular malignant melanomas.

Agnarsdóttir M, Sooman L, Bolander A, Strömberg S, Rexhepaj E, Bergqvist M, Ponten F, Gallagher W, Lennartsson J, Ekman S, Uhlen M, Hedstrand H.

Melanoma Res. 2010 Dec;20(6):468-78. doi: 10.1097/CMR.0b013e3283403ccd.

PMID:
20890226
2.
3.

Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.

Shin J, Vincent JG, Cuda JD, Xu H, Kang S, Kim J, Taube JM.

J Am Acad Dermatol. 2012 Oct;67(4):717-26. doi: 10.1016/j.jaad.2011.12.035. Epub 2012 Feb 9.

PMID:
22325460
4.

Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.

Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA.

Clin Cancer Res. 2003 Aug 15;9(9):3383-8.

5.

Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.

Bakos RM, Maier T, Besch R, Mestel DS, Ruzicka T, Sturm RA, Berking C.

Exp Dermatol. 2010 Aug;19(8):e89-94. doi: 10.1111/j.1600-0625.2009.00991.x.

6.
7.

Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions.

Böni R, Wellmann A, Man YG, Hofbauer G, Brinkmann U.

Am J Dermatopathol. 1999 Apr;21(2):125-8.

PMID:
10218671
8.

Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.

Boyd AS, Shakhtour B, Shyr Y.

J Am Acad Dermatol. 2008 May;58(5):750-4. doi: 10.1016/j.jaad.2007.12.026. Epub 2008 Feb 4.

PMID:
18249467
9.
10.

HER3 expression in cutaneous tumors.

Wimmer E, Kraehn-Senftleben G, Issing WJ.

Anticancer Res. 2008 Mar-Apr;28(2A):973-9.

11.

SOX10 expression in malignant melanoma, carcinoma, and normal tissues.

Mohamed A, Gonzalez RS, Lawson D, Wang J, Cohen C.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):506-10. doi: 10.1097/PAI.0b013e318279bc0a.

PMID:
23197006
12.

RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.

Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L.

Cancer Res. 2007 Apr 1;67(7):3064-73.

13.

Sox10: a pan-schwannian and melanocytic marker.

Nonaka D, Chiriboga L, Rubin BP.

Am J Surg Pathol. 2008 Sep;32(9):1291-8. doi: 10.1097/PAS.0b013e3181658c14.

PMID:
18636017
14.

Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.

Roesch A, Becker B, Meyer S, Wild P, Hafner C, Landthaler M, Vogt T.

Mod Pathol. 2005 Sep;18(9):1249-57.

15.

Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.

Clarke LE, Fountaine TJ, Hennessy J, Bruggeman RD, Clarke JT, Mauger DT, Helm KF.

J Cutan Pathol. 2009 Apr;36(4):433-8. doi: 10.1111/j.1600-0560.2008.01077.x.

PMID:
19278428
16.

Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.

Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R.

J Pathol. 2001 Dec;195(5):530-6.

PMID:
11745687
17.

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.

Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, Moretti D, Lio R, Massi D.

Hum Pathol. 2010 Apr;41(4):503-12. doi: 10.1016/j.humpath.2009.09.004. Epub 2009 Dec 11.

PMID:
20004946
18.

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.

Talve L, Sauroja I, Collan Y, Punnonen K, Ekfors T.

Int J Cancer. 1997 Jun 20;74(3):255-9.

PMID:
9221801
19.

Analysis of APAF-1 expression in human cutaneous melanoma progression.

Baldi A, Santini D, Russo P, Catricalà C, Amantea A, Picardo M, Tatangelo F, Botti G, Dragonetti E, Murace R, Tonini G, Natali PG, Baldi F, Paggi MG.

Exp Dermatol. 2004 Feb;13(2):93-7.

PMID:
15009102
20.

Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.

Zembowicz A, Knoepp SM, Bei T, Stergiopoulos S, Eng C, Mihm MC, Stratakis CA.

Am J Surg Pathol. 2007 Nov;31(11):1764-75.

PMID:
18059235
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk